{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:21:39Z","timestamp":1772896899968,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120575","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T21:48:17Z","timestamp":1756072097000},"page":"120575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Activity values of the enzyme phosphomanomutase 2 for diagnosing the CDG Ia glycosylation defect"],"prefix":"10.1016","volume":"578","author":[{"given":"Lina Marcela","family":"\u00c1vila Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson Samuel","family":"Agudelo Pe\u00f1aloza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2830-982X","authenticated-orcid":false,"given":"Adis Ayala","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120575_b0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0025-7753(04)74362-6","article-title":"Defectos cong\u00e9nitos de la glucosilaci\u00f3n: \u00faltimos avances y experiencia espa\u00f1ola","volume":"122","author":"Vilaseca","year":"2004","journal-title":"Med. Cl\u00edn."},{"key":"10.1016\/j.cca.2025.120575_b0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbadis.2008.11.002","article-title":"Glycosylation diseases: quo vadis?","volume":"1792","author":"Schachter","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2025.120575_b0015","unstructured":"Cerd\u00e1-P\u00e9rez, C., Gir\u00f3s, M., Serrano, B., P\u00e9rez-Due\u00f1as, B., Ecay, M., Medrano, C., et al. (n.d.) Protocolo de diagn\u00f3stico y tratamiento de los defectos cong\u00e9nitos de glicosilaci\u00f3n. https:\/\/www.rarecommons.org\/files\/images\/imce\/CDG\/protocolo_cdg.pdf."},{"key":"10.1016\/j.cca.2025.120575_b0020","series-title":"Bioqu\u00edmica Ilustrada","author":"Murray","year":"2012"},{"key":"10.1016\/j.cca.2025.120575_b0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41420-023-01560-5","article-title":"Research progress on post-translational modification of proteins and cardiovascular diseases","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.cca.2025.120575_b0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tins.2020.03.011","article-title":"Post-translational modifications of opioid receptors","volume":"43","author":"Lemos Duarte","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.cca.2025.120575_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893365","article-title":"N-glycosylation and inflammation; the not-so-sweet relation","volume":"13","author":"Radovani","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120575_b0040","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4161\/self.1.3.12330","article-title":"Glycosylation: an intrinsic sign of \u201cdanger\u201d","volume":"1","author":"Rachmilewitz","year":"2010","journal-title":"Self\/nonself"},{"issue":"6","key":"10.1016\/j.cca.2025.120575_b0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nature Rev. Nephrology"},{"key":"10.1016\/j.cca.2025.120575_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.11.003","article-title":"The challenge of CDG diagnosis","volume":"126","author":"Francisco","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2025.120575_b0055","doi-asserted-by":"crossref","first-page":"9155","DOI":"10.1016\/S0021-9258(19)76520-X","article-title":"The yeast SEC53 gene encodes phosphomannomutase","volume":"263","author":"Kepes","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2025.120575_b0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y","article-title":"Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG\u2010Ia)","volume":"16","author":"Matthijs","year":"2000","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.cca.2025.120575_b0065","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/ijms19082218","article-title":"The analysis of variants in the general population reveals that PMM2 is extremely tolerant to missense mutations and that diagnosis of PMM2-CDG can benefit from the identification of modifiers","volume":"19","author":"Citro","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120575_b0070","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/humu.22817","article-title":"The effects of PMM2\u2010CDG\u2010causing mutations on the folding, activity, and stability of the PMM2 protein","volume":"36","author":"Yuste-Checa","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2025.120575_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1003989","article-title":"MAN1B1 deficiency: an unexpected CDG-II","volume":"9","author":"Rymen","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cca.2025.120575_b0080","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/humu.21126","article-title":"Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol\u2010linked oligosaccharides","volume":"30","author":"Haeuptle","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2025.120575_b0085","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejpn.2008.09.002","article-title":"Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations","volume":"13","author":"P\u00e9rez-Due\u00f1as","year":"2009","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.cca.2025.120575_b0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbadis.2009.01.003","article-title":"The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)","volume":"1792","author":"Gr\u00fcnewald","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2025.120575_b0095","series-title":"Physician's Guide to the Diagnosis, Treatment, and Follow-up of Inherited Metabolic Diseases","first-page":"483","article-title":"Congenital disorders of glycosylation","author":"Blau","year":"2014"},{"key":"10.1016\/j.cca.2025.120575_b0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12311-021-01242-x","article-title":"Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG)","volume":"20","author":"Pettinato","year":"2021","journal-title":"Cerebellum"},{"key":"10.1016\/j.cca.2025.120575_b0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13023-014-0207-4","article-title":"29 French adult patients with PMM2-congenital disorder of glycosylation: Outcome of the classical pediatric phenotype and depiction of a late-onset phenotype","volume":"9","author":"Monin","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.cca.2025.120575_b0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.gene.2013.07.083","article-title":"PMM2-CDG: Phenotype and genotype in four affected family members","volume":"531","author":"Bortot","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.cca.2025.120575_b0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/adc.85.3.236","article-title":"Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H\/F119L genotype","volume":"85","author":"Kjaergaard","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cca.2025.120575_b0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002470050571","article-title":"Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1","volume":"29","author":"Antoun","year":"1999","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.cca.2025.120575_b0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1203\/01.pdr.0000246802.57692.ea","article-title":"Congenital disorders of N-glycosylation including diseases associated with O-as well as N-glycosylation defects","volume":"60","author":"Leroy","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cca.2025.120575_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13023-015-0358-y","article-title":"Phosphomannomutase deficiency (PMM2-CDG): Ataxia and cerebellar assessment","volume":"10","author":"Serrano","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.cca.2025.120575_b0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00401-004-0975-3","article-title":"Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology","volume":"109","author":"Aronica","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cca.2025.120575_b0140","series-title":"Biomarkers in Inborn Errors of Metabolism: Clinical Aspects and Laboratory Determination","first-page":"343","article-title":"Chapter 15: Congenital disorders of glycosylation","author":"Garg","year":"2017"},{"key":"10.1016\/j.cca.2025.120575_b0145","unstructured":"Ministerio de Salud y Protecci\u00f3n Social (n.d.) Actualizaci\u00f3n de listado de enfermedades hu\u00e9rfanas 2018. https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/resolucion-5265-de-2018.pdf."},{"key":"10.1016\/j.cca.2025.120575_b0150","series-title":"Biochemical genetics. A laboratory manual","author":"Shapira","year":"1989"},{"key":"10.1016\/j.cca.2025.120575_b0155","unstructured":"Ayala, A. (2009) Protocolo para la cuant\u00edficaci\u00f3n de prote\u00ednas por el m\u00e9todo de Folin-Lowry, Gu\u00edas de laboratorio de Bioqu\u00edmica y Biolog\u00eda Molecular, Bogot\u00e1 D.C."},{"key":"10.1016\/j.cca.2025.120575_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","article-title":"A fluorimetric enzyme assay for the diagnosis of Morquio disease type a (MPS IV a)","volume":"187","author":"van Diggelen","year":"1990","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120575_b0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0014-5793(95)01357-1","article-title":"Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I","volume":"377","author":"van Schaftingen","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2025.120575_b0170","first-page":"41","article-title":"Enzyme assays","volume":"1","author":"Bisswanger","year":"2014","journal-title":"Persp. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120575_b0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.18359\/rmed.3358","article-title":"M\u00e9todo microespectrofotom\u00e9trico para la determinaci\u00f3n de valores de referencia de la fosfomanosa isomerasa","volume":"27","author":"Samac\u00e1-Mart\u00edn","year":"2019","journal-title":"Rev. Med."},{"key":"10.1016\/j.cca.2025.120575_b0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2014.06.021","article-title":"Mannose metabolism: more than meets the eye","volume":"453","author":"Sharma","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2025.120575_b0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0076-6879(02)53050-0","article-title":"Functional evaluation of non phagocytic NAD(P)H oxidases","volume":"353","author":"Miller","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cca.2025.120575_b0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.10278","article-title":"Niemann\u2010Pick disease type B: an unusual clinical presentation with multiple vertebral fractures","volume":"109","author":"Volders","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.cca.2025.120575_b0195","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10719-008-9137-5","article-title":"Hexosaminidase assays","volume":"26","author":"Wendeler","year":"2009","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.cca.2025.120575_b0200","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00125817-200111000-00003","article-title":"Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia","volume":"3","author":"Westphal","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2025.120575_b0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/glycob\/8.2.165","article-title":"Abnormal synthesis of mannose 1-phosphate derived carbohydrates in carbohydrate-deficient glycoprotein syndrome type I fibroblasts with phosphomannomutase deficiency","volume":"8","author":"K\u00f6rner","year":"1998","journal-title":"Glycobiology"},{"key":"10.1016\/j.cca.2025.120575_b0210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/318199","article-title":"High residual activity of PMM2 in patients\u2019 fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)","volume":"68","author":"Gr\u00fcnewald","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2025.120575_b0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1005351927573","article-title":"Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency)","volume":"21","author":"Barone","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2025.120575_b0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2008.11.024","article-title":"Plasma lysosomal enzyme activities in congenital disorders of glycosylation, galactosemia and fructosemia","volume":"401","author":"Michelakakis","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120575_b0225","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10545-005-0157-z","article-title":"Elevation of plasma aspartylglucosaminidase is a useful marker for the congenital disorders of glycosylation type I (CDG I)","volume":"28","author":"Jackson","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.cca.2025.120575_b0230","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13023-020-01528-z","article-title":"Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)","volume":"15","author":"Taday","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.cca.2025.120575_b0235","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13023-021-01988-x","article-title":"Mannose supplementation in PMM2-CDG","volume":"16","author":"Taday","year":"2021","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125004541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:44:14Z","timestamp":1772826254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125004541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0009898125004541"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120575","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity values of the enzyme phosphomanomutase 2 for diagnosing the CDG Ia glycosylation defect","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120575"}}